Ignite Creation Date:
2025-12-24 @ 4:49 PM
Ignite Modification Date:
2026-01-01 @ 8:22 AM
Study NCT ID:
NCT05664750
Status:
COMPLETED
Last Update Posted:
2024-03-08
First Post:
2022-12-07
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study to Compare the Efficacy and Safety of Passive Immunization With TNM002 Injection and Human Tetanus Immunoglobulin as Prophylaxis Against Tetanus
Sponsor:
Zhuhai Trinomab Pharmaceutical Co., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-12-22
Start Date Type:
ACTUAL
Primary Completion Date:
2023-03-24
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-07-07
Completion Date Type:
ACTUAL
First Submit Date:
2022-12-07
First Submit QC Date:
None
Study First Post Date:
2022-12-27
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2024-03-08
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2024-03-06
Last Update Post Date:
2024-03-08
Last Update Post Date Type:
ACTUAL